RNF180
Basic information
Region (hg38): 5:64165843-64372869
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the RNF180 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 26 | 32 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 26 | 6 | 0 |
Variants in RNF180
This is a list of pathogenic ClinVar variants found in the RNF180 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
5-64200847-C-A | not specified | Uncertain significance (Mar 18, 2024) | ||
5-64200916-G-A | not specified | Likely benign (Feb 15, 2023) | ||
5-64200931-C-G | not specified | Uncertain significance (Aug 30, 2021) | ||
5-64212125-G-A | not specified | Uncertain significance (Feb 02, 2024) | ||
5-64213604-G-A | not specified | Uncertain significance (Nov 30, 2022) | ||
5-64213637-A-C | not specified | Uncertain significance (Jul 11, 2023) | ||
5-64213786-A-G | not specified | Uncertain significance (Apr 08, 2022) | ||
5-64213835-G-A | not specified | Likely benign (Nov 15, 2021) | ||
5-64213847-A-G | not specified | Likely benign (Jan 04, 2024) | ||
5-64213886-G-A | not specified | Uncertain significance (Jan 24, 2024) | ||
5-64213905-G-A | not specified | Uncertain significance (Jun 24, 2022) | ||
5-64213919-T-C | not specified | Uncertain significance (Dec 21, 2021) | ||
5-64214072-A-G | not specified | Uncertain significance (Apr 15, 2024) | ||
5-64214116-A-T | not specified | Uncertain significance (Jun 11, 2021) | ||
5-64214146-A-G | not specified | Uncertain significance (Nov 08, 2022) | ||
5-64214157-C-G | not specified | Uncertain significance (Aug 10, 2023) | ||
5-64214159-A-G | not specified | Likely benign (Nov 04, 2023) | ||
5-64214256-T-A | not specified | Uncertain significance (May 03, 2023) | ||
5-64214267-T-C | not specified | Uncertain significance (Mar 01, 2024) | ||
5-64214296-A-G | not specified | Likely benign (Jun 27, 2022) | ||
5-64214308-A-G | not specified | Uncertain significance (Sep 06, 2022) | ||
5-64214329-C-G | not specified | Uncertain significance (May 14, 2024) | ||
5-64214390-T-C | not specified | Uncertain significance (Aug 22, 2023) | ||
5-64214495-G-A | not specified | Likely benign (Aug 16, 2021) | ||
5-64325200-G-C | not specified | Uncertain significance (Mar 14, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
RNF180 | protein_coding | protein_coding | ENST00000389100 | 7 | 207026 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.00000276 | 0.983 | 125708 | 0 | 37 | 125745 | 0.000147 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.624 | 257 | 287 | 0.896 | 0.0000141 | 3922 |
Missense in Polyphen | 16 | 20.687 | 0.77345 | 262 | ||
Synonymous | 0.0902 | 100 | 101 | 0.989 | 0.00000478 | 1080 |
Loss of Function | 2.18 | 13 | 24.7 | 0.526 | 0.00000132 | 337 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000393 | 0.000391 |
Ashkenazi Jewish | 0.000199 | 0.000198 |
East Asian | 0.000272 | 0.000217 |
Finnish | 0.0000462 | 0.0000462 |
European (Non-Finnish) | 0.0000882 | 0.0000879 |
Middle Eastern | 0.000272 | 0.000217 |
South Asian | 0.000327 | 0.000327 |
Other | 0.000163 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: E3 ubiquitin-protein ligase which promotes polyubiquitination and degradation by the proteasome pathway of ZIC2. {ECO:0000250|UniProtKB:Q3U827}.;
Recessive Scores
- pRec
- 0.0769
Intolerance Scores
- loftool
- 0.268
- rvis_EVS
- 0.11
- rvis_percentile_EVS
- 61.91
Haploinsufficiency Scores
- pHI
- 0.413
- hipred
- N
- hipred_score
- 0.170
- ghis
- 0.515
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.626
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Rnf180
- Phenotype
- homeostasis/metabolism phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan);
Gene ontology
- Biological process
- protein polyubiquitination;adult behavior;positive regulation of protein ubiquitination;positive regulation of proteasomal ubiquitin-dependent protein catabolic process;norepinephrine metabolic process;serotonin metabolic process;regulation of catalytic activity
- Cellular component
- nuclear envelope;integral component of membrane;intrinsic component of endoplasmic reticulum membrane
- Molecular function
- ubiquitin conjugating enzyme binding;metal ion binding;ubiquitin protein ligase activity